PT  - JOURNAL ARTICLE
AU  - Bertram Pitt
AU  - Sanjay Rajagopalan
TI  - Aldosterone receptor antagonists for heart failure: Current status, future indications
DP  - 2006 Mar 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 257--268
VI  - 73
IP  - 3
4099  - http://www.ccjm.org/content/73/3/257.short
4100  - http://www.ccjm.org/content/73/3/257.full
SO  - Cleve Clin J Med2006 Mar 01; 73
AB  - Many patients with heart failure should receive an aldosterone receptor antagonist, ie, either spironolactone (Aldactone) or the newer agent eplerenone (Inspra)—in addition to an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB) or both, and a beta-blocker. We review the evidence and indications.